re: patent fight and competition. In defense of Syringe, it appears his comments are well informed and considered. Yes, his financial desire is to see vcr fail, but it is a judgement based on detailed research and considered comparisons.
I am very much a novice investor, but I do appreciate every person's right to pass informed, non-emotive comment to anyone prepared to listen.
I listen and I make up my own mind. Keep doing what you are doing syringe, it's your right. As is the right to ignore.
all the best to all
- Forums
- ASX - By Stock
- VCR
- next fall will be to 90 cents
VCR
ventracor limited